Raymond James Financial Inc Neuroone Medical Technologies Corp Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 14,850 shares of NMTC stock, worth $10,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,850Holding current value
$10,692% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NMTC
# of Institutions
35Shares Held
13.5MCall Options Held
125KPut Options Held
0-
Bleichroeder LP New York, NY4MShares$2.88 Million0.86% of portfolio
-
Sio Capital Management, LLC New York, NY3.52MShares$2.54 Million1.14% of portfolio
-
Bard Associates Inc Chicago, IL1.85MShares$1.34 Million0.47% of portfolio
-
Perkins Capital Management Inc1.47MShares$1.06 Million1.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$865,8700.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $11.7M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...